You are here

Article metrics

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Liraglutide, a GLP-1 receptor agonist, prevents cardiovascular outcomes in patients with type 2 diabetes

 

Online download statistics by month:

Online download statistics by month: November 2016 to October 2024

AbstractFullPdf
Nov 20161862423
Dec 2016143815
Jan 20172432430
Feb 20171751523
Mar 20171422120
Apr 201761179
May 20175889
Jun 201731168
Jul 201753103
Aug 20175943
Sep 201713975
Oct 2017135144
Nov 20179297
Dec 20176721
Jan 20188742
Feb 201810372
Mar 20189194
Apr 20186542
May 20187497
Jun 20185800
Jul 20186332
Aug 201810297
Sep 20188631
Oct 20186310
Nov 20185401
Dec 20188587
Jan 20194385
Feb 20197310
Mar 20194012
Apr 20194952
May 20193820
Jun 20194438
Jul 20193941
Aug 20193332
Sep 20193704
Oct 20195031
Nov 201983135
Dec 20194000
Jan 20207733
Feb 20208121
Mar 20206410
Apr 20202000
May 20204522
Jun 20204510
Jul 20206322
Aug 20202200
Sep 20205240
Oct 20203310
Nov 20205050
Dec 20203000
Jan 20213311
Feb 20218010
Mar 20214331
Apr 20212600
May 2021611
Jun 2021110
Jul 2021200
Aug 2021220
Sep 2021112
Oct 20211500
Nov 20212500
Dec 20215723
Jan 20222030
Feb 20223110
Mar 20223600
Apr 20223420
May 20224400
Jun 20226701
Jul 20223210
Aug 20226910
Sep 20223910
Oct 20224200
Nov 20222611
Dec 20221600
Jan 20231921
Feb 20234800
Mar 2023800
Apr 20232200
May 20231300
Jun 2023200
Jul 20231000
Aug 20231611
Sep 20231301
Oct 20232211
Nov 20231400
Dec 20233410
Jan 20242000
Feb 20244461
Mar 20244021
Apr 20244210
May 20245110
Jun 20243900
Jul 20243411
Aug 20243322
Sep 20245031
Oct 20245120
Total5038345253